Ian Collins
Ian Collins
Verified email at deakin.edu.au
TitleCited byYear
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations
KA Phillips, IM Collins, RL Milne, SA McLachlan, M Friedlander, M Hickey, ...
Human Reproduction 31 (5), 1126-1132, 2016
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers
IM Collins, RL Milne, PC Weideman, SA McLachlan, ML Friedlander, ...
Med J Aust 199 (10), 680-3, 2013
Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into …
IM Collins, RL Milne, SA McLachlan, M Friedlander, M Hickey, ...
J Clin Oncol 31 (31), 3920-5, 2013
The tubal hypothesis of ovarian cancer: caution needed
IM Collins, SM Domchek, DG Huntsman, G Mitchell
The lancet oncology 12 (12), 1089-1091, 2011
Assessing and managing breast cancer risk: Clinicians' current practice and future needs
IM Collins, E Steel, GB Mann, JD Emery, A Bickerstaffe, A Trainer, ...
The Breast 23 (5), 644-650, 2014
Women’s preferences for selective estrogen reuptake modulators: an investigation using the time trade-off technique
AF Ralph, B Ager, ML Bell, IM Collins, L Andrews, K Tucker, N O’Reilly, ...
SpringerPlus 3 (1), 264, 2014
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management
IM Collins, A Bickerstaffe, T Ranaweera, S Maddumarachchi, L Keogh, ...
Breast cancer research and treatment 156 (1), 171-182, 2016
Women's preferences for selective estrogen reuptake modulators: an investigation using protection motivation theory
AF Ralph, B Ager, ML Bell, IM Collins, L Andrews, K Tucker, KA Phillips, ...
Patient education and counseling 96 (1), 106-112, 2014
Strategies for fertility preservation after chemotherapy awareness among Irish Cancer specialists
IM Collins, MJ Kennedy
Irish Medical Journal, 2011
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?
KA Phillips, EJ Steel, I Collins, J Emery, M Pirotta, GB Mann, P Butow, ...
Australian journal of primary health 22 (3), 255-261, 2016
Carboplatin Dosing in Ovarian Cancer: Problems and Pitfalls
IM Collins, R Roberts-Thomson, D Faulkner, D Rischin, M Friedlander, ...
International Journal of Gynecological Cancer 21 (7), 1213, 2011
Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor
IM Collins, P Beddy, KJ O'BYRNE
Acta oncologica 49 (6), 872-874, 2010
A Role for IGF-1R–Targeted Therapies in Small-Cell Lung Cancer?
K Gately, I Collins, L Forde, B Al-Alao, V Young, M Gerg, F Feuerhake, ...
Clinical Lung Cancer 12 (1), 38-42, 2011
Electronic clinical decision support systems attitudes and barriers to use in the oncology setting.
IM Collins, O Breathnach, P Felle
Irish Journal of Medical Science, 2012
Terminology and Details of the Diagnostic Process for Testis Cancer
SS Connolly, PJA Daly, MSJ Floyd Jr, IM Collins, R Grainger, JA Thornhill
The Journal of urology 185 (3), 876-880, 2011
Clinical Decision Aids in Colon Cancer; A Comparison of Two Predictive Nomograms
IM Collins, F Kelleher, C Stuart, M Collins, J Kennedy
Clinical Colorectal Cancer, 2011
Novel Approaches to Treatment of Leiomyosarcomas
IM Collins, DM Thomas
Current oncology reports, 1-7, 2011
Adjuvant trastuzumab in HER2-positive breast cancer.
IM Collins, P Francis, L Mileshkin
The New England journal of medicine 366 (7), 664; author reply 664, 2012
Bisphosphonate induced osteonecrosis of the jaws: Unravelling uncertainty in disease causality
FC Kelleher, M McKenna, C Collins, G Brady, I Collins, J Crown
Acta oncologica 46 (5), 702-704, 2007
Rechallenge with imatinib in GIST: is more always RIGHT?
D Urban, J Lewin, IM Collins, J Mooi, M Jefford
The Lancet Oncology 15 (1), e2-e3, 2014
The system can't perform the operation now. Try again later.
Articles 1–20